Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · IEX Real-Time Price · USD
6.71
+0.19 (2.91%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Cogent Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
0007.8722.59.738.366.362.99
Revenue Growth (YoY)
----65.02%131.14%16.44%31.55%112.83%-
Gross Profit
0007.8722.59.738.366.362.99
Selling, General & Admin
34.3826.2119.6417.4210.977.454.683.432.73
Research & Development
173.76121.6355.9125.7443.7138.2929.8321.996.85
Other Operating Expenses
00046.9100000
Operating Expenses
208.13147.8475.5590.0754.6845.7434.5125.439.58
Operating Income
-208.13-147.84-75.55-82.2-32.18-36.01-26.15-19.07-6.59
Other Expense / Income
-15.72-7.6-3.28-7.39-0.35-1.47-0.66-0.95-
Pretax Income
-192.41-140.24-72.27-74.81-31.83-34.53-25.49-18.12-6.59
Net Income
-192.41-140.24-72.27-74.81-31.83-34.53-25.49-18.12-6.59
Preferred Dividends
000104.400.020.070.060.04
Net Income Common
-192.41-140.24-72.27-179.21-31.83-34.55-25.56-18.19-6.64
Shares Outstanding (Basic)
8059391186333
Shares Outstanding (Diluted)
8059391186333
Shares Change
35.61%51.66%249.52%45.42%22.43%144.27%0.02%--
EPS (Basic)
-2.42-2.39-1.87-16.17-4.18-5.56-10.04-7.12-2.60
EPS (Diluted)
-2.42-2.39-1.87-16.17-4.18-5.56-10.04-7.12-2.60
Free Cash Flow
-156.42-125.5-60.48-35.53-41.34-33.04-26.75-21.9515.72
Free Cash Flow Per Share
-1.96-2.14-1.56-3.21-5.43-5.31-10.50-8.626.17
Gross Margin
---100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
----1044.33%-143.02%-369.89%-312.82%-300.08%-220.76%
Profit Margin
----2276.81%-141.49%-354.92%-305.71%-286.20%-222.20%
Free Cash Flow Margin
----451.40%-183.75%-339.41%-319.94%-345.35%526.52%
EBITDA
-188.82-134.36-70.28-74.09-30.54-33.21-24.32-17.29-6.41
EBITDA Margin
----941.28%-135.74%-341.19%-290.92%-272.13%-214.77%
Depreciation & Amortization
3.595.881.990.721.291.321.170.830.18
EBIT
-192.41-140.24-72.27-74.81-31.83-34.53-25.49-18.12-6.59
EBIT Margin
----950.43%-141.49%-354.76%-304.93%-285.19%-220.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).